key: cord-0889999-3jz2lo18 authors: Senerat, Araliya M.; Pope, Zachary; Rydell, Sarah; Mullan, Aidan; Roger, Veronique; Pereira, Mark A. title: Psychosocial and Behavioral Outcomes and Transmission Prevention Behaviors: Working during COVID-19 date: 2021-08-28 journal: Mayo Clin Proc Innov Qual Outcomes DOI: 10.1016/j.mayocpiqo.2021.08.014 sha: a00a50b1a766c4724182ed499c94eb056c2b6712 doc_id: 889999 cord_uid: 3jz2lo18 Objective To investigate the impact of coronavirus disease-2019 (COVID-19) on psychosocial and behavioral responses of the non-healthcare workforce and evaluate transmission prevention behavior implementation at the workplace. Patients and Methods We deployed the baseline questionnaire of a prospective online survey from November 20, 2020-February 8, 2021 to U.S.-based employees. The survey included questions on psychosocial and behavioral responses in addition to transmission prevention behaviors (e.g., mask wear). Select questions asked employees to report perceptions and behaviors ‘before’ and ‘during’ the COVID-19 pandemic. Data were analyzed descriptively and stratified by work from home (WFH) percentage. Results In total, 3,607 employees completed the survey from eight companies. Most participants (70.0%) averaged ≥90% of their time WFH during the pandemic. Employees reported increases in stress (54.0%), anxiety (57.4%), fatigue (51.6%), and feeling unsafe (50.4%) from before to during the pandemic, while feeling a lack of companionship (60.5%) and isolation from others (69.3%). Productivity was perceived to decrease, and non-work screen time and alcohol consumption to increase, for 43.0%, 50.7%, and 25.1% of employees, respectively, from before to during the pandemic. Adverse changes were worse among those with lower WFH percentages. Most employees reported wearing a mask (98.2%), washing hands regularly (95.7%), and physically distancing (93.6%) when at workplace. Conclusion Results suggested worsened psychosocial and behavioral outcomes from before to during the COVID-19 pandemic and higher transmission prevention behavior implementation among non-healthcare employees. Observations provide novel insight into how the COVID-19 pandemic has impacted non-healthcare employees. Coronavirus disease-2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), has resulted in high morbidity and mortality since being declared a global pandemic in March 2020. [1] [2] [3] As most SARS-CoV-2 infections are likely transmitted by asymptomatic individuals prior to symptom onset, 4 infection control measures have been and continue to be vital even as effective vaccines are administered. Across many workforce sectors, companies have implemented mitigation strategies, including mandates that employees work from home (WFH), if possible, while also requiring engagement in SARS-CoV-2 transmission prevention behaviors (e.g., physical distancing, mask wear). [5] [6] [7] While these mitigation strategies may help reduce COVID-19 infection rates, unintended negative consequences on employees may arise (e.g., stress/anxiety, adverse behavior changes). The COVID-19 pandemic has led to increased prevalence [8] [9] [10] [11] [12] [13] [14] of higher self-reported stress, anxiety, depression, episodes of acute panic, obsessive behaviors, and post-traumatic stress syndrome (PTSD), among others. 10 Widespread quarantine and fear of self/loved ones getting COVID-19 are among the largest contributors to observed poorer psychosocial health. 10, 11 Mental health problems are also higher among those diagnosed with COVID-19 compared to those not directly affected. 15 Within the workplace, past literature noted that being a healthcare worker or caregiver with SARS-CoV in 2003 was associated with higher likelihood of negative psychosocial outcomes, exacerbating the impact of the COVID-19 pandemic on this employee cohort. 10 How past infectious diseases and the COVID-19 pandemic have impacted the psychosocial health of non-healthcare employees has scantly been studied. SARS-CoV-2 spreads primarily via small airborne infectious particles (i.e., aerosols) that infected individuals may generate when breathing, coughing, sneezing, or talking. [16] [17] [18] [19] [20] [21] [22] A less J o u r n a l P r e -p r o o f Senerat -7 common transmission route is via larger respiratory droplets that deposit onto nearby surfaces. [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] A recent meta-analysis 34 and several standalone investigations [35] [36] [37] [38] [39] [40] have shown the ability of mask wearing, physical distancing, and hand/surface disinfection to mitigate transmission of various coronaviruses. Thus, SARS-CoV-2 transmission prevention behaviors in the workplace are critical to reduce COVID-19 infection rates, with engagement in these behaviors also associated with lower levels of stress, anxiety, and depression. 11 Governmental recommendations are in place for SARS-CoV-2 transmission prevention at the workplace. 41 Yet, few data exist across non-healthcare employee workforce sectors regarding: (1) psychosocial outcomes (e.g., stress, anxiety, safety) and perceptions as it relates to working during the COVID-19 pandemic; (2) behavioral outcomes (e.g., smoking, alcohol consumption, physical activity); and (3) implementation of SARS-CoV-2 transmission prevention behaviors at the workplace. Survey collection of such data would inform workplace strategies to reduce negative psychosocial outcomes among employees as more individuals return regularly to the workplace. The purpose of our study was to examine COVID-19-related psychosocial outcomes, prevention practices, and health behaviors among employees across numerous workforce sectors. This study was approved by the University of Minnesota (IRB #: STUDY00010426) and Mayo Clinic (IRB #: 20-007642) Institutional Review Boards. All study participants gave informed consent. The CAPTURE Survey was deployed using the Mayo Clinic's Qualtrics Platform. Survey responses were deidentified and given a unique study ID that consisted of a series of numbers that had no meaning to employees' personal identifying characteristics. We used this ID to track each individual employee in the research database. Company-level inclusion criteria were: (1) any public or private company; and (2) inbusiness at time of baseline survey distribution. We assessed these company-level criteria before contacting each company regarding their employees' potential participation in the CAPTURE Survey. Employee-level inclusion criteria were: (1) ≥18 years old; (2) English speaking; (3) currently employed by the company; and (4) working ≥50% of their workweek indoors given J o u r n a l P r e -p r o o f that SARS-CoV-2 is most likely to spread indoors. Employees were excluded if they were: (1) <18 years old; (2) unemployed; (3) working primarily outdoors; and (4) did not work within the U.S. We excluded employees working outside the U.S. given the differing cultures, practices, and severity of the COVID-19 pandemic between the U.S. and other countries. We gathered employee's age, employment status, employer (i.e., company), and U.S. location. Average percentage of workweek time working indoors was assessed on a 0-100% scale in 1%-increments. Demographic information, job descriptions, and general health-related information were adapted from the Stand and Move at Work (SMW) group randomized trial and the Coronary Artery Risk Development in Young Adults (CARDIA) study. 42, 43 Socioeconomic Impact of Questions assessed the average number of hours/week that the employee worked in total and face-to-face at the workplace. We assessed average percentage of workweek hours spent WFH on a 0-100% scale in 1%-increments, with this question asked in parallel to acquire 'before' and 'during' COVID-19 WFH percentages. Questions adapted from the SMW trial and the Environmental Influences on Child Health Outcomes (ECHO) study examined health insurance coverage and doctors visits before and during COVID-19. 43, 44 We used 5-point Likert scales to assess the following: employee's frequency of feeling stressed, anxious, fatigued, and unsafe before and during COVID-19; employees' perceived productivity before and during COVID-19; whether employees felt threatened or afraid of COVID-19; employees' fear of catching the disease when around other people; and employee J o u r n a l P r e -p r o o f engagement in health behaviors before and during COVID-19, including physical activity, nonwork-related screen time, sleep, and alcohol consumption. These questions were adapted from the SMW trial. 43 We included questions that asked about frequency of: (1) SARS-CoV-2 transmission prevention behaviors (mask wear, glove wear, handwashing, physical distancing, surface disinfection) that an employee and their coworkers have taken when at the workplace; and (2) company provision of SARS-CoV-2 transmission prevention supplies. These questions were asked on a 5-point Likert-scale. We also assessed types of SARS-CoV-2 transmission prevention behavior training provided by employees' companies and whether the employee perceived SARS-CoV-2 transmission prevention behaviors to be effective at preventing the spread of COVID-19, the latter on a 4-point Likert-scale. We inquired whether the employee had experienced any COVID-19 symptoms and/or We contacted a convenience sample of 234 U.S. companies regarding CAPTURE Survey participation through word of mouth, emails, LinkedIn messages, and website form submissions. companies returning correspondence. A short, informational presentation was provided to key contacts of interested companies that outlined the survey's aims, company and employee participation requirements, and the potential benefits of the company's participation. Companies were given two survey deployment choices if they agreed to have employees participate: (1) company sent out a company-wide email with survey link and informational materials that invited employee participation; or (2) company collected email addresses of interested employees and shared those email addresses with us to deploy the survey. Four companies chose to generate their own company-wide deployment email, and we sent out company-provided emails to four companies. While employees from participating companies were strongly encouraged to participate, they were told participation was completely voluntary and had no effect on their company employment or relationship with us. The survey was sent to employees of participating companies starting November 20, 2020, and closed February 8, 2021. A reminder email was sent approximately 5-7 business days after initial deployment, with the survey open to employees of a given company for up to three weeks after the initial deployment date. CAPTURE Survey responses were downloaded from Mayo Clinic's Qualtrics Platform. Data were cleaned using Microsoft Excel and uploaded to Python 3.9 for further cleaning and analyses using Jupyter Notebook for Windows 1.3.1093. Duplicates were examined by the date of first survey completion and CAPTURE Survey progress completion for each duplicate entry. Of the duplicates, we kept the CAPTURE Survey entry with the highest progress completion. In addition to determining prevalence and mean responses for the entire cohort, we also stratified by WFH categories: ≤25%, 26-50%; 51-75%; >75%. Further, we compared employee J o u r n a l P r e -p r o o f responses to questions asking about psychosocial experiences, perceptions, and health behaviors 'before' and 'during' the COVID-19 pandemic. Likert responses were coded numerically and the mean change between responses 'before' and 'during' the pandemic was calculated for the whole sample as well as by WFH categories with 95% confidence intervals. A total of 3,607 employees completed the survey from eight separate companies across the U.S. Seven companies were considered industry and included industries such as transportation, manufacturing, and commercial facilities management. One company was an academic institution. The overall mean response rate from employees within the eight companies was 14.9%, with intra-company response rates ranging from 6.8% to 63.8%. When analyses were stratified by company type (industry vs. academic), results were not materially different. Demographic results are observed in Table 1 . Most employees were from the Midwest (83.5%). Mean age was 44.7 ± 12.1 years, with most classified as 'Professionals' (49.5%), followed by 'Executive, Administrator, or Senior Manager' (13.5%), and 'Clerical and Administrative Support' (11.8%). Perceived health was 'Good', 'Very Good', or 'Excellent' for most (91.7%). The percentage of employees reporting that their doctor had told them they had a medical condition ranged from 2.9% for heart disease and stroke (combined) to 24.0% for mood disorder. Most employees (62.1%) reported reduced in-person contact with family who live outside the home, friends, colleagues at work, and events in the community because of COVID-19. Senerat -13 Most (85.7%) employees stated they spent >90% of their time indoors when working, 90.5% stated they spent an average of 33-60 hours per week working, and 58.8% stated they currently had no face-to-face, in-person interactions with either coworkers or the public while completing their job-related duties. Few employees (0.2%) reported being furloughed or furloughed previously (or temporarily laid off). Approximately 68% believed COVID-19 had a negative impact on their work. Few (0.7%) lost health insurance or other coverage for medical care. As shown in Supplemental Figure 1 , with WFH percentage grouped into the four 25% categories, the distribution shifts dramatically from 'before' to 'during' the COVID-19 pandemic. During the pandemic, many employees reported feeling stressed (53.1%), anxious (43.8%), and fatigued (41.1%) 'Quite a bit' or 'All the time'. The prevalence of employees agreeing they felt threatened about COVID-19 or afraid of COVID-19 were 39.4% and 60.0%, respectively, while 60.3% reported being stressed around other people because they worried they would catch COVID-19. In total, 32.4% reported being 'Moderately' or 'Very Worried' about contracting COVID-19 while at work, and 34.1% reported being 'Moderately' or 'Very Worried' about being an asymptomatic carrier. Table 2 shows the changes in psychosocial and behavioral responses from before to during the COVID-19 pandemic, with mean change and 95% confidence intervals for each parameter. More than half of employees reported an increase in stress, anxiety, fatigue, feeling unsafe, a lack of companionship, and a feeling of being isolated from others. For the behavioral J o u r n a l P r e -p r o o f outcomes, a high percentage of employees reported a decrease in productivity and physical activity, while increases were observed for non-work screen time, sleep, and alcohol consumption. Figure 2 shows the mean change and 95% confidence intervals for the psychosocial and behavioral responses stratified by WFH categories of >75% (n = 2,682) vs. ≤25% (n = 509) of worktime. As shown, mean increases were higher in the ≤25% WFH group for stress, anxiety, fatigue, and feeling unsafe. Decreases in productivity were larger for WFH ≤25%, while an increase in sleep was only observed in WFH >75%. We also ran additional analyses comparing those 100% WFH (n = 2,017) to those 0% WFH (n = 214) to the >75% WFH (n = 2,682) and ≤25% WFH (n = 509) groups. This sensitivity analysis did not change the results materially and, therefore, to preserve statistical power, we only provided the results for the >75% WFH and ≤25% WFH groups. Employees reported 'Often' or 'Always' engaging in personal SARS-CoV-2 transmission prevention behaviors at the workplace, as seen in Table 3 . Glove wearing was an exception, with most reporting 'Never' or 'Rarely'. Table 3 When asked about perceptions of the importance of specific prevention behaviors and practices, most employees reported wearing a mask, handwashing, and physical distancing to be 'Very Important' (93.3%, 89.1%, and 93.5%, respectively). Disinfecting surfaces was reported as J o u r n a l P r e -p r o o f Senerat -15 'Very Important' by some (45.5%), while most employees reported that wearing gloves was 'Not Important' (36.2%). COVID-19 symptoms reported as lasting several hours more than usual were headaches (34.3%), followed by unusual fatigue (27.1%), malaise or general feeling of illness, discomfort or uneasiness (23.2%), and muscle aches (22.3%). In total, 13.1% of employees suspected they had a COVID-19 infection or had COVID-19 symptoms. Most reported having a negative nasal swab or saliva test (52.9%) and a negative blood/antibody test (9.9%). Few had a positive nasal swab or saliva test (4.0%) and positive blood/antibody test (1.0%). We observed large increases in stress, anxiety, fatigue, and feeling unsafe among nonhealthcare employees due to the COVID-19 pandemic. We also noted an increase in lack of companionship, feeling left out, or isolation when completing work-related duties, with decreased productivity and physical activity reported. Most employees were afraid of COVID-19 and stressed about acquiring the disease in general. Interestingly, however, not as many employees were worried about contracting COVID-19 at work or being an asymptomatic carrier of COVID-19 while at work, regardless of WFH status. A high percentage of employees believed wearing a mask, handwashing, and physical distancing were important in preventing the spread of COVID-19. While productivity and physical activity decreased for many, non-work screen time increased. Sleep also increased in a small percentage of employees and, in particular, Research has shown adverse psychosocial changes during the COVID-19 pandemic, with higher levels of anxiety, depression, PTSD, and stress observed among the general population in multiple countries. 15 In the U.S., a survey conducted from March through June 2020 found that distress increased as the pandemic first emerged in the U.S., including increases in anxiety and depression. 48 Literature has suggested psychosocial support to be critical to mitigating these adverse changes, as individuals reporting having no psychosocial support were more vulnerable to mental health problems during the COVID-19 pandemic. 49 These observations align with our findings from employees across the U.S. and suggest employers might need to make concerted efforts to assist employees in dealing with mental health issues as more individuals return to the physical workplace. Notably, our observations suggest that the focus of employers may need to be most concentrated on those who have worked the least amount of time at home during COVID-19. Our behavioral outcome observations were also largely consistent with previous research on the COVID-19 pandemic. Increased non-work technology usage 14 and screen time 50 have been seen in previous studies. Interestingly, we saw a slight increase in hours of sleep per night among employees >75% WFH each week, but not among employees ≥ 25% WFH each week. Despite the increased sleep duration observed among some, other research during the COVID-19 pandemic has suggested individuals' sleep quality has been poorer. 14 Reductions in physical activity were also observed in existing research. 50 More investigation of these phenomena, as well as changes in alcohol consumption, may be warranted. We believe our ongoing follow-up CAPTURE Surveys will provide more insight. A secondary aim of CAPTURE was to assess personal SARS-CoV-2 transmission prevention behaviors taken at the workplace to mitigate the spread of COVID-19. While wearing a mask, washing hands regularly, physically distancing from coworkers, and monitoring symptoms were reported in high percentages, wearing gloves and disinfecting surfaces were not as common. This may be explained by the changing viewpoints of SARS-CoV-2 spread and associated mitigation strategy guidance set forth by the CDC 51 and the World Health Organization's (WHO) 52 suggesting that surface-based transmission is less common. Importantly, employees reported their companies to be highly supportive of SARS-CoV-2 transmission prevention behavior engagement. Indeed, many companies provided COVID-19 prevention training for their employees, which may have also aided in the high percentage of prevention behaviors reported. Study limitations should be noted. First, participants were a convenience sample. Over 200 companies were contacted, but the companies that did partake in the survey had previously worked with, or were connected to, the research institutions. This convenience sample skewed the educational status of participants, with more than half of participants having a graduate degree. Second, while we asked about job status, we did not ask if employees identified as essential or non-essential workers due to the multidimensional nature of the companies. Future questionnaires should include perceptions of essential worker status or have a defined strategy to determine if employees are considered essential or non-essential workers. Finally, this was a cross-sectional analysis of a prospective survey. The questions asking about outcomes and perceptions "Before COVID-19" were retrospective and subject to recall bias. However, followup papers will describe prospective observations of the ongoing CAPTURE surveys. feeling unsafe due to work-related duties, as well as adverse changes in health behaviors (e.g., increased non-work screen time, decreased physical activity), suggest companies might consider how to support their employees as employees begin to return to the office in greater numbers. Holmes Please enter the email address* at which you received this survey: *Please note that we will only ask for your email so that we may contact you with an invitation to complete the survey at 3-, 6-, and 12-month timepoints. All emails are maintained in a secure, password-protected database that will only be used to contact you at the future timepoints. Emails will be deidentified (stripped) from all responses prior to data analysis. Please see consent form for more information. Thank you for your willingness to complete this survey! It should take no longer than 20 minutes to complete. As you will see, some questions are personal in nature, and others assess work-related behaviors as they relate to the current coronavirus disease-19 (COVID-19) pandemic. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus causing COVID-19, refers to the illness caused by the novel coronavirus that was first identified in 2019. We realize there are many different opinions on both the severity of, and responses to, the pandemic. Please know that your answers to these questions are strictly confidential and study results will only be presented in summary form. With that, we ask you to be honest in your responses. When answering these questions, please only think about your work at [Company]. We very much appreciate your time and honesty. If you have any questions while taking this study, please email the study coordinator. Below is a list of symptoms that may be related to COVID-19. Some of these may also occur with other conditions such as allergies, colds and flu or when taking certain medications. Have you had any of these symptoms for longer than several hours or more than is usual for you, since March 2020? Prefer not to answer Johns Hopkins Coronavirus Resource Center WHO director-general's opening remarks at the media briefing on COVID-19 -11 Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area Temporal dynamics in viral shedding and transmissibility of COVID-19 Applying principles of behaviour change to reduce SARS-CoV-2 transmission What we know so far: COVID-19 current clinical knowledge and research Using social and behavioural science to support COVID-19 pandemic response The differential psychological distress of populations affected by the COVID-19 pandemic. Brain, behavior, and immunity The authors thank the staff of the Well Living Lab for their support. We acknowledge Qingyang Liu for her helpful guidance with analyzing the data, Laura Kjarland for assistance with survey deployment, and Austin Hoeg for his assistance with the project. Data Sharing Policy: Our data are available upon specific request to the corresponding author.